Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Adaptimmune TherapeuticsAlectorPassage BioCellectisAgenus
SymbolNASDAQ:ADAPNASDAQ:ALECNASDAQ:PASGNASDAQ:CLLSNASDAQ:AGEN
Price Information
Current Price$4.53$9.41$17.67$17.08$4.04
52 Week RangeBuyBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score1.41.41.61.21.5
Analysis Score3.33.53.33.33.5
Community Score2.52.43.02.92.8
Dividend Score0.00.00.00.00.0
Ownership Score1.01.01.00.01.0
Earnings & Valuation Score0.00.00.60.00.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$16.50$32.80$28.50$34.83$7.00
% Upside from Price Target264.24% upside248.57% upside61.29% upside103.94% upside73.27% upside
Trade Information
Market Cap$728.61 million$768.05 million$803.76 million$788.54 million$770.46 million
Beta2.130.55N/A2.131.98
Average Volume936,7101,025,200216,375183,5631,673,859
Sales & Book Value
Annual Revenue$1.12 million$21.22 millionN/A$22.99 million$150.05 million
Price / Sales526.2535.15N/A31.574.94
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$1.18 per share$2.83 per shareN/A$8.37 per share($1.68) per share
Price / Book3.843.33N/A2.04-2.40
Profitability
Net Income$-137,160,000.00$-105,390,000.00N/A$-102,090,000.00$-107,660,000.00
EPS($1.32)($1.71)N/A($2.41)($0.80)
Trailing P/E RatioN/AN/A0.00N/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-5,687.30%-775.34%N/A-89.50%-176.80%
Return on Equity (ROE)-58.60%-50.88%N/A-18.00%N/A
Return on Assets (ROA)-42.69%-28.63%N/A-13.83%-98.07%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/A0.02%N/A
Current Ratio11.88%7.75%26.05%6.56%0.74%
Quick Ratio11.88%7.75%26.05%6.45%0.74%
Ownership Information
Institutional Ownership Percentage98.57%62.99%69.43%32.74%49.07%
Insider Ownership Percentage18.89%13.90%N/A16.41%5.20%
Miscellaneous
Employees4069120161328
Shares Outstanding130.11 million79.26 million45.49 million42.49 million183.44 million
Next Earnings Date11/4/2020 (Estimated)11/10/2020 (Estimated)11/12/2020 (Estimated)11/4/2020 (Estimated)10/29/2020 (Confirmed)
OptionableOptionableNot OptionableNot OptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.